PRINCETON, N.J., July 11, 2013 /PRNewswire/ -- Omthera Pharmaceuticals, Inc. (the "Company") announced today that BofA Merrill Lynch and Barclays, the lead book-running managers in the Company's recent public sale of 8,000,000 shares of common stock, is waiving a lock-up restriction with respect to all outstanding shares of the Company's common stock held by the shareholders, officers and directors of the Company in connection with certain dispositions related to the Company's announced definitive merger agreement with an affiliate of AstraZeneca PLC. The waiver will take effect on July 15, 2013, and the shares may be disposed of on or after such date in accordance with the terms of the waiver.

This press release is not an offer for sale of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as amended.

About Omthera Pharmaceuticals, Inc.

Omthera Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development and commercialization of new therapies for dyslipidemia and the treatment of cardiovascular disease. Epanova™, currently the Company's sole product candidate, is a late-stage, novel, omega-3 free fatty acid composition that meaningfully reduces triglycerides, improves other key lipid parameters and is expected to increase patient convenience with 2-gram once-a-day dosing with or without meals. Epanova™ is a coated soft gelatin capsule containing a complex mixture of polyunsaturated free fatty acids derived from fish oils, including multiple long-chain omega-3 and omega-6 fatty acids, with EPA, DHA, and docosapentaenoic acid being the most abundant forms of omega-3 fatty acids. The Company has co'/>"/>

(Date:7/31/2015)... Calif. , July 31, 2015 Xencor, Inc. ... engineered monoclonal antibodies for the treatment of autoimmune diseases, ... appointment of Yujiro S. Hata to its ... experience in business and corporate development is a tremendous ... Ph.D., president and chief executive officer of Xencor. "Xencor ...

... When treating the diabetes patient, doctors discussed how ... is not enough to reveal an individual,s risk ... of Clinical Endocrinologists (AACE) 18th Annual Meeting & ... ) "We need to be more aggressive in ...

(Date:7/31/2015)... ... 31, 2015 , ... Last week, the Mesothelioma Applied Research ... be accessed by visiting http://www.curemeso.org/store . , “Our new store features a ... whenever a product is purchased, the Meso Foundation receives a $5.00 donation,” said ...

(Date:7/31/2015)... ... ... According to an article published July 2 on Healio, a ... consensus on the steps that need to be taken to successfully complete several plastic ... on a series of steps that each surgeon must complete for each procedure. Southern ...

... ... ... Institutions currently using point-of-care resources from EBSCO Publishing (EBSCO) and ... access to their evidence-based resources, resulting in quicker retrieval of relevant and current information ...

... , , PARSIPPANY, ... Prevention (CDC) announced the start of National Influenza Vaccination Week. While ... it also brings to light the importance of taking additional steps ... and flu season of December, January and beyond. , "It,s easy ...

... , NEW ORLEANS, Dec. 6 ... excessive bleeding when a blood vessel is injured. Sometimes, however, ... injury or do not dissolve naturally, a potentially life-threatening situation ... of the American Society of Hematology reveals that the practice ...

... three-drug combination has shown in a phase 1/2 clinical ... treatment of patients newly diagnosed with multiple myeloma, a cancer ... Dana-Farber Cancer Institute. Partial responses or better were seen ... combination in the multi-center study, with 74 percent having a ...

The collagen intracanicular plugs have a smooth proprietary finish that simplifies insertion of the plug. Collagen plugs are ideal for short term, diagnostic and post-surgical occlusion. Plugs are 2m...

Form should always follow function. Thats why EagleVision created the FlexPlug, the only tapered shaft punctum plug with contouring traction ribs. Designed to provide the ultimate in flexibility, fix...

... the Attain Prevail's steerable tip, along with ... to obtain the curve you need, when ... improved visualization of the cardiac venous anatomy, ... Telescoping - Adjust curve and reach ...